Download
https://www.ndtvprofit.com/buzzing-stocks/piramal-pharma-shares-hit-52-week-high-after-q3-operating-profit-leaps-threefold?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The growth in Ebitda was driven by a decline in raw material and energy prices as well as cost optimisation, according to an exchange filing on Tuesday.
Share